+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Rubidium-82"

Radiopharmaceuticals Market - Products and Applications - Product Thumbnail Image

Radiopharmaceuticals Market - Products and Applications

  • Report
  • April 2025
  • 307 Pages
  • Global
From
From
Nuclear Medicine Radioisotopes Market Report 2025 - Product Thumbnail Image

Nuclear Medicine Radioisotopes Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
From
Diagnostic Radioisotopes Market Report 2025 - Product Thumbnail Image

Diagnostic Radioisotopes Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Diagnostic Radioisotopes Market - Global Strategic Business Report - Product Thumbnail Image

Diagnostic Radioisotopes Market - Global Strategic Business Report

  • Report
  • February 2026
  • 487 Pages
  • Global
From
From
From
From
Radiopharmaceutical Market - Product Thumbnail Image

Radiopharmaceutical Market

  • Report
  • May 2024
  • 200 Pages
  • Global
From
From
  • 12 Results (Page 1 of 1)
Loading Indicator

Rubidium-82 (Rb-82) is a radioactive isotope used in Nuclear Medicine and Radiopharmacology. It is produced through the irradiation of natural rubidium with a cyclotron, and is used in the diagnosis and treatment of cardiovascular diseases. Rb-82 is used in positron emission tomography (PET) imaging, which is a non-invasive imaging technique used to detect and diagnose diseases. It is also used in myocardial perfusion imaging, which is a type of imaging used to assess the function of the heart. Rb-82 is a short-lived isotope with a half-life of only 1.27 minutes, making it ideal for use in Nuclear Medicine and Radiopharmacology. It is also relatively inexpensive compared to other isotopes used in Nuclear Medicine. Companies in the Rubidium-82 market include GE Healthcare, Bracco Imaging, Mallinckrodt Pharmaceuticals, and Lantheus Medical Imaging. Show Less Read more